| 标题： | RET变异甲状腺诊疗中国专家共识 |
| title： | Chinese expert consensus on diagnosis and treatment of RET altered thyroid |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 甲状腺癌相关临床医生、病理医生 |
| Guide users： | Thyroid cancer-related clinicians and pathologists |
| 证据分级方法： | 美国牛津循证医学中心 |
| Evidence grading method： | Oxford Centre for Evidence-based Medicine |
| 制定单位： | 中国抗癌协会甲状腺癌专委会和中华医学会肿瘤分会甲状腺肿瘤专委会 |
| Formulating unit： | Thyroid Cancer Committee of China Anti-Cancer Association and Thyroid Cancer Committee of Chinese Medical Association Tumor Branch |
| 注册时间： | 2024-07-16 |
| Registration time： | |
| 注册编号： | PREPARE-2024CN1003 |
| Registration number： | |
| 指南制订的目的： | 本共识专家组基于现有的研究证据，结合我国临床实践经验，提出了RET变异甲状腺癌的诊疗规范流程，包括分子检测人群、检测时机、检测方法、治疗方案选择及不良反应管理等，以期为临床医师提供指引。 |
| Purpose of the guideline： | Based on the existing research evidence and my country's clinical practice experience, this consensus expert group proposes a standardized process for the diagnosis and treatment of RET altered thyroid, including molecular testing populations, testing timing, testing methods, treatment options, and adverse reaction management, with a view to providing Clinicians provide guidance. |
最新注册
